HitGen Ltd announced that the company has entered into a research collaboration with Almirall to identify novel small molecule leads for targets of interest. In this collaboration, HitGen will apply its advanced technology platform, based on DNA-encoded l
HitGen and Pfizer have entered a multi-year research collaboration and licence agreement to build and screen novel DNA-encoded libraries (DELs) to help discover unique small-molecule leads for use in drug development.